Merck aim to solve the toughest problems in the industry. They excel at any modification, any target, and any cell type, including the most challenging cell lines. Their team of PhD Scientists and R&D centric environment allows collaborative communication with scientists, access to Merck's gene editing tools portfolio (CRISPR/Cas9, Zinc Finger Nuclease, Lentivirus), and state-of-the-art technologies and instrumentation. Engineered cell lines can be developed for research and drug discovery, or development with GMP-like documentation for biomanufacturing or batch release assays. With insights and applications across the complete spectrum of development challenges, Cell Design Studio® can help you take your project from research to reality.